Medical News

RSS

Link between elevated blood sugar levels in diabetics and increased risk of life-threatening forms of cardiovascular disease

A Johns Hopkins study suggests that people with type I and type II diabetes would be well advised to monitor their blood sugar levels more than the usual twice daily to make sure that levels are not elevated over 150 milligrams per deciliter for sustained periods.

20 Sep 2004

Vanilla may become a drug to treat sickle cell disease

In addition to its popular role in flavoring ice cream, fudge and cake frosting, vanilla may have a future use as a medicine. Recent laboratory research has strengthened the possibility that a form of vanilla may become a drug to treat sickle cell disease.

20 Sep 2004

Link between mother’s stress levels during pregnancy and the effect on the brain of her unborn baby

An intriguing link between a mother’s stress levels during pregnancy and the effect on the brain of her unborn baby is revealed in a new study of children born in Bristol, England.

20 Sep 2004

Discovery of dopamine terminal injury in brains of people with HIV dementia

Scientists at the U.S. Department of Energy’s Brookhaven National Laboratory have discovered a key mechanism in the brains of people with human immunodeficiency virus (HIV) dementia.

20 Sep 2004

Scientists unlock the crucial communication pathways of p53 protein cells

Professor Nicholas La Thangue and his team at the Institute of Biomedical and Life Sciences at the University of Glasgow have unlocked the crucial communication pathways of p53 protein cells, which could ultimate aid the slowing down of cells that cause tumours and related disease.

20 Sep 2004

Investigation into the potential for designing drug treatments based on a person’s genetic makeup

Most current drugs are not effective for 100 per cent of the population and some work in as few as 30 to 50 per cent of cases. Pharmacogenetics, the study of how genetic factors influence a person’s response to a drug, is seen as a way of making treatments as safe and effective as possible for every individual.

20 Sep 2004

Disabled people need better specialist equipment

For many disabled people, assistive technology is crucial to their ability to choose how they want to live and whether they can live independently.

20 Sep 2004

Non-human primates should never be considered as source animals for any future clinical trials of animal-to-human transplantation

Australia’s leading health advisory body, the National Health and Medical Research Council, says there should be a five-year moratorium on any clinical research into animal-to-human whole organ transplants in Australia.

20 Sep 2004

Global health is recurrently being threatened by new and re-emerging infectious diseases

Global health is recurrently being threatened by new and re-emerging infectious diseases. Examples of new and re-emerging infectious diseases include SARS (Severe Acute Respiratory Syndrome), new variant CJD (Creutzfeldt-Jakob Disease), avian flu and Ebola.

20 Sep 2004

Study shows high levels of body dissatisfaction and unhealthy weight-control behaviours among contemporary black South African females

Black South African women have once more been flagged up as being on the brink of an eating disorder crisis, as the latest research reveals that their male counterparts, who once idolised fuller-figured females, now prefer thinner, Western-looking women.

20 Sep 2004

Data suggests potential role of Quadramet in conjunction with chemotherapy for the treatment of acute myeloid leukemia

Cytogen Corporation today announced the presentation of new data relating to its lead therapeutic product Quadramet (samarium Sm-153 lexidronam injection) during the 36th Congress of the International Society of Pediatric Oncology (SIOP).

20 Sep 2004

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Isis Pharmaceuticals announced today that Eli Lilly and Company licensed LY2275796, a second-generation antisense anti-cancer drug candidate for clinical development.

20 Sep 2004

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

Roche and GlaxoSmithKline announced today the submission of a Marketing Authorisation Application to the European authorities for a novel, once-monthly oral formulation of their new bisphosphonate, Bonviva (ibandronate), for the treatment of postmenopausal osteoporosis.

20 Sep 2004

Tarceva plus Gemcitabine improves survival compared to Gemcitabine alone

OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche announced today that results from a randomized Phase III clinical study of the investigational drug Tarceva (erlotinib HCl), in combination with gemcitabine chemotherapy met its primary endpoint of improving survival.

20 Sep 2004

Dementia is set to become one of the greatest health challenges for the Australian community

Australian Medical Association Vice-President, Dr Mukesh Haikerwal, said today that dementia is set to become one of the greatest health challenges for the Australian community over the next decade.

20 Sep 2004

New Australian biotech speeds up healing for burns and wounds

A Queensland PhD student’s discovery speeds up tissue growth and repair and sparks off a new listed biotech company.

20 Sep 2004

Breakthrough in spinal regeneration research

University of Queensland researchers are claiming a breakthrough in spinal regeneration research with the discovery of a molecule that blocks regrowth of damaged nerve processes.

20 Sep 2004

Laws against driving while using cell phones would have little effect on the number of accidents

In a new study issued by the American Enterprise Institute-Brookings Joint Center for Regulatory Studies, Prieger found that, while still at increased risk, drivers who use cell phones are less likely to have accidents by as much as 36 percent than previous studies predicted.

20 Sep 2004

Today’s scientists have the skills and experience to transplant a human face

A University of Louisville-led research team studying the face transplant has developed guidelines it says are critical to the success of the still-untried procedure.

20 Sep 2004

Less radiation in a more tailored manner best for uterine cancer

Less radiation, delivered in a more tailored manner, is very effective and should be preferred over longer-term conventional radiation therapy in treating one of the most virulent forms of uterine cancer

20 Sep 2004

Medical News

Link between elevated blood sugar levels in diabetics and increased risk of life-threatening forms of cardiovascular disease

Vanilla may become a drug to treat sickle cell disease

Link between mother’s stress levels during pregnancy and the effect on the brain of her unborn baby

Discovery of dopamine terminal injury in brains of people with HIV dementia

Scientists unlock the crucial communication pathways of p53 protein cells

Investigation into the potential for designing drug treatments based on a person’s genetic makeup

Disabled people need better specialist equipment

Non-human primates should never be considered as source animals for any future clinical trials of animal-to-human transplantation

Global health is recurrently being threatened by new and re-emerging infectious diseases

Study shows high levels of body dissatisfaction and unhealthy weight-control behaviours among contemporary black South African females

Data suggests potential role of Quadramet in conjunction with chemotherapy for the treatment of acute myeloid leukemia

Isis Pharmaceuticals licenses second anti-cancer drug candidate to Lilly

Bonviva, to treat osteoporosis, submitted for marketing authorisation in Europe

Tarceva plus Gemcitabine improves survival compared to Gemcitabine alone

Dementia is set to become one of the greatest health challenges for the Australian community

New Australian biotech speeds up healing for burns and wounds

Breakthrough in spinal regeneration research

Laws against driving while using cell phones would have little effect on the number of accidents

Today’s scientists have the skills and experience to transplant a human face

Less radiation in a more tailored manner best for uterine cancer

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News